| Característica |
Objectiu de la convocatòria
Collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer.
|
Característiques principals
These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@imim.es Ext.: 1576
Carol Barnwell: cbarnwell@imim.es Ext.1670
|
Convocatòria (URL)
https://themarkfoundation.org/endeavor/
|
Informació addicional
May 19, 2022: Grants portal opens for submission of Letters of Intent (LOI)
December 2022: Full applications due
|
Requisits
Institutional Eligibility:
Open to non-profit academic/research institutions worldwide.There is no requirement to include a US-based institution as part of the team.
Teams may comprise investigators from a single institutions or multiple institutions.
Institutions may submit more than one application; however, no more than one proposal per institution will be advanced to the finalist phase.
Investigator Eligibility:
There are no restrictions on citizenship or geography.
Must have an independent faculty research appointment (tenure-track or equivalent) at a non-profit academic institution.
Investigators may be co-PI or collaborator on more than one proposal but may only serve as Principal Investigator on one proposal.
Project Eligibility:
Basic, translational, and clinical projects are eligible.
The project must seek to address an overarching, urgent scientific question.
Sub-projects should be designed to elucidate various aspects of the overarching question, theme, or focus.
The output of the individual team members (data, samples, hypotheses, compounds, etc.) must be integrated and/or shared in a way that makes the impact of the project as a whole larger than the sum of its parts.
Proposed projects must not be supported by other sources of funding. Finalists will be asked to discuss any potential overlap with other current or pending awards.
Team Composition:
Teams must be composed of one PI, and between 2-8 co-PIs (see “Team Roles” section for definitions).
Inter-institutional collaborations are permitted and encouraged.
Teams are encouraged to consider diversity in terms of discipline, seniority, gender, race, ethnicity, and any other parameters that will enhance the team’s ability to approach challenging problems from fresh perspectives.
The Mark Foundation for Cancer Research does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability, or any other legally protected characteristics.
|
Dotació
Up to $1,000,000 per year for a total of three years.
|
Durada
Three years.
|
AVÍS IMPORTANT
Registration is now open for a webinar with additional information and details about the Endeavor Program, including an overview of the program, eligibility requirements, the application process, and a Q&A period. Attendance at the webinar is optional – all information presented will be posted on the Endeavor website in December:
May 19, 2022, 4:00 PM EST. Registration: https://us02web.zoom.us/webinar/register/WN_5HEmUqotT_Oacwju8Asj0g
|